Harvard Scientists praise Erchonia for their study on Zerona
The latest version of Lasers in Surgery and Medicine (medical journal) hosts an article (written by 3 Harvard Scientists) that evaluates the potential of laser therapy for body sculpting. The 3 scientists noticed that the research that Erchonia, manufacturer of the prestigious Zerona (testimonials here), conducted is absolutely valid and this is how an evaluation research should be carried out! As they mentioned, Erchonia “set the precedent on how aesthetic devices should be evaluated.” It is also important to notice that among the 3 researchers we meet Michael Hamblin PhD. a globally renowned expert regarding LLLT (Low Level Laser Therapy).
How was Erchonia’s study conducted?
Erchonia conducted a placebo controlled investigation of the Zerona laser evaluating 67 participants. The results are pretty impressive while the participants that had Zerona therapy experienced in only 2 weeks an average 3.51 inches reduction (the treatment focused on hips, thighs and waist)!
Why the three scientists gave credits to Erchonia? Because the clinical trial focused on Zerona Treatment without other restrictions (proper diet, exercising etc) that would probably affect the final results! So the study clearly showed how Zerona treatment on its own affects the body, without changing other factors.
The publication of the article made Steven Shanks, president of Erchonia comment “Having an expert such as Dr. Hamblin recognize the quality of our research and the clinical utility of Erchonia’s Zerona laser is truly an honor. For a small medical device manufacturer like Erchonia, quality clinical research is pivotal for our overall success. Erchonia’s research stands out in aesthetic medicine because more and more devices, such as Erchonia’s competitors, such as fat-freezing devices, are tested in non-randomized, non-controlled clinical trials.”
Zerona was praised again in 2011 by an article published in Clinics in Plastic Surgery which was reporting “Zerona is in a unique and beneficial category as it exemplifies a truly non-invasive approach, inducing slimming without cell death or upregulation of inflammation.”
If you ask us, such clinical trials should be praised but what matters even more is conducting independent clinical trials!
PS: You can find our impartial report on Zerona right here!